Current epidemiology of human plague in Madagascar

被引:66
作者
Chanteau, S
Ratsitorahina, M
Rahalison, L
Rasoamanana, B
Chan, F
Boisier, P
Rabeson, D
Roux, J
机构
[1] WHO Collaborating Ctr Plague, Inst Pasteur, Antananarivo, Madagascar
[2] Minist Hlth, Plague Natl Control Program, Antananarivo, Madagascar
关键词
plague; Yersinia pestis; epidemiology; lethality; resistance; Madagascar;
D O I
10.1016/S1286-4579(00)00289-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
From 1996 to 1998, 5 965 patients with suspected plague were identified in 38 districts of Madagascar (40% of the total population are exposed). Using standard bacteriology, 917 of them were confirmed or presumptive (C + P) cases. However, more than 2 000 plague cases could be estimated using F1 antigen assay. Two out of the 711 Yersina pestis isolates tested were resistant to chloramphenicol and to ampicillin (both isolates found in the harbour of Mahajanga). Urban plague (Mahajanga harbour and Antananarivo city) accounted for 37.4% of the C + P cases. Bubonic plague represented 97.2% of the cases, and the lethality rate was still high (20%). In comparing the exposed population, plague was more prevalent in males (M:F sex ratio 1.3:1)and patients under 20 years (2.7% babies under two years). Buboes were mainly localised in the inguinal/femoral regions (55.8%). The epidemiological risk factors are discussed. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 21 条
  • [1] [Anonymous], 1998, Wkly Epidemiol Rec, V73, P366
  • [2] Urban epidemic of bubonic plague in Majunga, Madagascar: Epidemiological aspects
    Boisier, P
    Rasolomaharo, M
    Ranaivoson, G
    Rasoamanana, B
    Rakoto, L
    Andrianirina, Z
    Andriamahefazafy, B
    Chanteau, S
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (05) : 422 - 427
  • [3] BRYGOO E. R., 1966, Arch. Inst. Pasteur Madagascar, V35, P9
  • [4] Plague, a reemerging disease in Madagascar
    Chanteau, S
    Ratsifasoamanana, L
    Rasoamanana, B
    Rahalison, L
    Randriambelosoa, J
    Roux, J
    Rabeson, D
    [J]. EMERGING INFECTIOUS DISEASES, 1998, 4 (01) : 101 - 104
  • [5] F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy
    Chanteau, S
    Rabarijaona, L
    O'Brien, T
    Rahalison, L
    Hager, J
    Boisier, P
    Burans, J
    Rasolomaharo, M
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1998, 92 (05) : 572 - 573
  • [6] Coulanges P, 1979, ARCH I PASTEUR MADAG, V56, P9
  • [7] FAVAREL R., 1948, BULL SOC PATH EXOT, V41, P576
  • [8] Multidrug resistance in Yersinia pestis mediated by a transferable plasmid
    Galimand, M
    Guiyoule, A
    Gerbaud, G
    Rasoamanana, B
    Chanteau, S
    Carniel, E
    Courvalin, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (10) : 677 - 680
  • [9] GIRARD G., 1927, BULL SOC PATH EXOT, V20, P233
  • [10] Recent emergence of new variants of Yersinia pestis in Madagascar
    Guiyoule, A
    Rasoamanana, B
    Buchrieser, C
    Michel, P
    Chanteau, S
    Carniel, E
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (11) : 2826 - 2833